In his latest Boston Globe column, Nick Cafardo lists 15 big-earning players who could be potential trade candidates this winter “with a little creativity” from their teams and any interested trade partners. Cafardo also has some hot stove buzz…
- One general manager says that Jose Quintana’s name didn’t come up in talks with the White Sox, leading the GM “to believe they’d like to hold on to him. [Chris] Sale was mentioned, [Carlos] Rodon was mentioned and all the others, but not Quintana.” Reports have the White Sox ready to listen on any player who isn’t under long-term control, though Quintana technically doesn’t fit this description. He is under contract through 2019 with a club option for 2020, and given how Quintana has pitched during his career, that early-career extension has become a bargain for the Sox. Rodon’s inclusion is interesting, as the highly-touted lefty can’t hit free agency until after the 2021 season, though just because Rodon’s name may have been mentioned in discussions obviously isn’t any sign that Chicago is exploring trades.
- A team’s senior advisor chimed in on Greg Holland’s recent showcase for scouts, saying that while Holland’s velocity was down, it was “good enough where you could see that if he rehabs properly he’ll get there. There was nothing there to excite you but nothing there to discourage you either.” Despite this rather unexciting review, Holland drew plenty of interest, as 18 teams reportedly sent personnel to watch Holland throw after missing all of 2016 rehabbing from Tommy John surgery. The senior advisor isn’t sure Holland will be able to find a two-year/$20-22MM offer that has been “floated” in connection with him. MLBTR predicted slightly less (two years, $18MM) for the reliever, though as evidenced by the Brett Cecil signing earlier today, there could be some surprising numbers on the relief market this offseason.
- Mike Napoli has been getting some interest from National League teams as a full-time first baseman. This is a obviously a good sign for Napoli’s market, as it shows that NL teams aren’t necessarily scared away by his age (35) or increased DH usage last season in Cleveland. Napoli’s defensive metrics at first were below average in 2016, after years of delivering very solid glovework throughout his career.
- Bronson Arroyo is three or four weeks away from knowing if a stem-cell procedure from Dr. James Andrews has properly healed his elbow. If the veteran righty is finally healthy, Arroyo is eager to continue his career. “I definitely want to keep going. Baseball is in my DNA,” Arroyo said. “I think when you’re in my position, you have to give it every chance, seeking everything medically available to see if you can keep doing it. The stem-cell injection was the last hope. If it doesn’t work, I know I’ve given it every chance.” Arroyo, who turns 40 in February, was a model of durability throughout his long career but he hasn’t pitched in the bigs since June 2014 due to both Tommy John surgery and then shoulder problems.